Cryoport, a cryogenic logistics services provider for the life sciences, has launched the Cryoport Biotech Regenerative Therapy Activity Index (the “CoBRA Index”) designed to quantify the activity in the development and clinical trials of regenerative therapies in the U.S., and acts as a means to help evaluate investment in the space.   Regenerative therapies include various technologies and therapeutic approaches, the majority being cell and gene therapies to treat a wide variety...